Royal DSM and Amyris, Inc. have expanded their ongoing collaboration with the sale of Amyris Brasil Ltda to DSM, along with the establishment of a long-term manufacturing partnership for Amyris’ high-volume products.   The sale of Amyris Brasil Ltda (which owns and operates the Brotas 1 production facility), intellectual property related to farnesene (a bio-based key intermediate for many applications), and an additional value share arrangement over a three-year period amounted to $96 mi...